Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 90 of 90 publications.

Odom DM, McLeod LD, Sherif BN, Nelson LM. Methods to assess the association of patient-reported outcomes and clinical endpoints. Presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Wang J, Odom D, Chirila C, Zheng Q. Evaluation of matching-adjusted indirect comparison implemented by a resampling method. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Chang J, Odom D, Radder C, Kappeler C, Xu R-h, Qin S, Kim TW, Li J. A post-hoc health-related quality of life analysis of patients with metastatic colorectal cancer in the phase III CONCUR trial. Poster presented at the ASCO Gastrointestinal Symposium 2015; May 2015. Chicago, IL. [abstract] J Clin Oncol. 2015 May; 33(Suppl 3):a667.

Gottlieb AB, Strober B, Lebwohl M, Kaufmann R, Pariser D, Narbutas R, Nyirady J, Zhao Y, Tran MH, McLeod L, Odom D, Elewski B. Secukinumab in psoriasis: relationship between clinical- and patient-reported outcomes using clinical trial data from the ERASURE and FIXTURE trials. Poster presented at the 73rd Annual Meeting of the American Academy of Dermatology; March 2015. San Francisco, CA.

Elewski B, Lebwohl M, Strober B, Szepietowski JC, Blauvelt A, Schlessinger J, Nyirady J, Zhao Y, Tran MH, McLeod L, Odom D, Gottlieb AB. Secukinumab in psoriasis: early improvement in patient-reported symptom diary predicts clinical response. Poster presented at the 73rd Annual Meeting of the American Academy of Dermatology; March 2015. San Francisco, CA.

Chang J, Odom DM, Radder CN, Kappeler C, Xu R, Qin S, Kim T, Li J. A post-hoc health-related quality of life (HRQoL) analysis of patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial. Poster presented at the 2015 Gastrointestinal Cancers Symposium; January 15, 2015. San Francisco, CA.

Matharu M, Pascual J, Nilsson Remahl L, Straube A, Johannes C, Odom D, Gutierrez L, Andrews E, Lum A. Interim analysis of the real-world utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine in an observational study in the European Union. Poster presented at the International Headache Conference; May 14, 2015. Valencia, Spain. [abstract] Cephalalgia. 2015; 35(6S):39.

Gottlieb A, Zhao Y, Odom DM, Tran MH, Strober B. Secukinumab's time to psoriasis response on patient-reported psoriasis symptoms (ERASURE Study). Poster presented at the 15th Annual Las Vegas Dermatology Seminar; October 30, 2014. Las Vegas, NV.

Gottlieb A, Zhao Y, Odom DM, Tran MH, Strober B. Secukinumab's time to psoriasis response on patient-reported symptoms (ERASURE Study). Poster presented at the 33rd Anniversary Fall Clinical Dermatology Conference; October 16, 2014. Las Vegas, NV.

Matharu M, Pascual J, Nilsson Remahl I, Odom D, Gutierrez L, Andrews E, Largent J, Johannes C. EHMTI-0192. Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union. Poster presented at the 4th European Headache and Migraine Trust International Congress 2014; September 2014. Copenhagen, Denmark. [abstract] J. Headache Pain. 2014 Sep 18; 15(Suppl 1):G24. doi: 10.1186/1129-2377-15-S1-G24

Odom DM, Chirila C, Sherrill EH, Wang J, Sherif BN. Practical issues when conducting network meta-analyses with a limited number of studies. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.

Odom DM, Mladsi DM, Saag KG, Sherif BN, Miles L, Ronquest N, Wang J. Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews. Clin Ther. 2014 Jun;36(6):906-17. doi: 10.1016/j.clinthera.2014.04.012.

Gottlieb AB, Zhao Y, Odom DM, Tran MH, Strober B. Secukinumab's time to psoriasis response on patient-reported psoriasis symptoms (ERASURE study). Poster presented at the Society of Dermatology Physicians Assistants Annual Summer Dermatology Conference; May 29, 2014. Indianapolis, IN. Previously presented at the 72nd Annual Meeting of the American Academy of Dermatology.

Glück S, Russell C, O'Shaughnessy J, McKenna EF, Hu S, Odom D, Blum JL. Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: results of an exploratory analysis. Breast. 2013 Dec;22(6):1087-93. doi: 10.1016/j.breast.2013.08.016.

Odom DM, Talbird SE, Brogan AJ, Schenkel B. A meta-analysis of randomized, controlled trials of ustekinumab and adalimumab for moderate-to-severe psoriasis. Poster presented at the Summer Meeting of the American Academy of Dermatology; August 2013.

Odom DM, Mladsi DM, Saag K, Ronquest NA, Wang J. Estimating the relationship between diclofenac drug dosage and risk of gastrointestinal toxicity: meta-regression based on a systematic literature review. Poster presented at the 2013 Digestive Disease Week; May 2013. Orlando, FL. [abstract] Gastroenterology. 2013 May; 144(5 Suppl 1):S-673. doi: 10.1016/S0016-5085(13)62496-8

Odom D, Brogan AJ, Talbird SE, Schenkel B. A network meta-analysis of randomized, controlled trials of ustekinumab and adalimumab for moderate-to-severe psoriasis. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. [abstract] Value Health. 2013 May; 16(3):A112. doi: 10.1016/j.jval.2013.03.532

Chirila C, Odom D, Devercelli G, Khan S, Sherif BN, Kaye JA, Molnar I, Sherrill B. Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer. Int J Colorectal Dis. 2012 May 1;27(5):623-34.

Odom D, Barber B, Bennett L, Peeters M, Zhao Z, Kaye J, Wolf M, Wiezorek J. Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab. Int J Colorectal Dis. 2011 Feb 1;26(2):173-81.

Blum JL, Kohles J, McKenna E, Scotto N, Hu S, Odom D, Kaye JA, Glück S. Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials. Breast Cancer Res Treat. 2011 Jan 1;125(2):431-9.

Chirila C, Odom D, Devercelli G, Khan S, Sherif B, Kaye J, Molnar I, Sherrill B. Meta-analysis of the validity of progression-free survival as a surrogate endpoint for overall survival in metastatic colorectal cancer trials. Poster presented at the 35th European Society for Medical Oncology Congress; October 12, 2010. [abstract] Ann Oncol. 2010 Oct; 21(suppl 8):623P.

Johannes C, Odom D, Bennett L, Foley D. The impact of menopause status on formal vs. informal care-seeking behavior in women with decreased sexual desire with associated distress. J Sex Med. 2010 May 1;7(Suppl. 3):123.

Johannes CB, Clayton AH, Odom DM, Rosen RC, Russo PA, Shifren JL, Monz BU. Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry. 2009 Dec 1;70(12):1698-706.

Oglesby A, Sherif B, Odom D, Leahy M, Qian Y. Time and costs associated with preparing and administering zoledronic acid in patients with breast or prostate cancer and metastatic bone disease. Community Oncol. 2009 Nov 1;6(11):494-502.

Odom DM, Bennett L, Irish W, Mladsi DM. Statistical methods to handle incomplete longitudinal patient-reported outcomes data in advanced disease stage trials. Presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France.

Rosen R, Shifren J, Monz B, Odom D, Russo P, Johannes C. The predictors of sexual distress in women with low sexual desire. Presented at the Annual Meeting of the International Society for the Study of Women's Sexual Health; September 1, 2009.

Glück S, Russell C, O'Shaughnessy J, Yuan G, Odom DM, Sherrill B, Blum J. Relationship between survival and estrogen receptor status in patients with metastatic breast cancer treated with capecitabine and docetaxel: an exploratory data analysis. Poster presented at the 2009 ASCO Annual Meeting; June 4, 2009.

Blum J, Hu S, Odom DM, Sherrill B, Glück S. Effect of age on overall survival in capecitabine- treated patients with metastatic breast cancer. Poster presented at the 2009 ASCO Annual Meeting; June 4, 2009.

Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med. 2009 Jun 1;6(6):1549-60.

Odom D, Devercelli G, Bennett L, Peeters M, Wolf M, Amado R. Health-related quality of life (HRQOL) and colorectal cancer (CRC) symptoms in metastatic CRC: panitumumab plus best supportive care (BSC) versus bsc alone by kras tumor status. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 12, 2008. [abstract] Value Health. 2008 Nov; 11(6):487.

Odom DM, Wang J, Irish W. Meta-regression of placebo response. Poster presented at the Proceedings of the American Statistical Association, Biopharmaceutical Section; September 2008. Washington, DC.

Grau EA, Frechtel PA, Odom DM. A simple evaluation of the predictive mean neighborhoods imputation procedure. Poster presented at the Proceedings of the American Statistical Association, Section on Survey Research Methods; August 1, 2004. Toronto, Canada.

Grau EA, Frechtel PA, Odom DM, Painter D. A simple evaluation of the imputation procedures used in nsduh. Presented at the Proceedings of the Survey Research Methods Section, American Statistical Association; August 1, 2004. Toronto, Canada.

Chromy J, Odom DM, Eyerman J, McNeeley M, Hughes A. The effect of interviewer experience on the interview process in the national survey on drug use and health. Poster presented at the Proceedings of the American Statistical Association, Section on Survey Research Methods; August 2003. San Francisco, CA.

Odom DM, Stivers J. The effects of September 11th on unit nonresponse in the national survey on drug use and health. Poster presented at the American Association for Public Opinion Research; 2002.

Packer L, Odom DM, Chromy J, Davis T, Gfroerer J. Changes in NHSDA measures of substance use initiation. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.185-220.

Eyerman J, Odom DM, Wu S, Butler D. Nonresponse in the 1999 NHSDA. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.23-51.

Hughes A, Chromy J, Giacoletti K, Odom DM. Impact of interviewer experience on respondent reports of substance use.. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.161-84.

Eyerman J, Odom DM, Chromy J, Gfroerer J. Impact of computerized screening on selection probabilities, response rates, and prevalence rates in the 1999 NHSDA. Poster presented at the Proceedings of the American Statistical Association, Section of Survey Research Methods; August 2001. Alexandria, VA.

Odom DM, Kalsbeek W. Further analysis of call history from the behavioral risk factor surveillance system. Poster presented at the Proceedings of the American Statistical Association, Section of Survey Research Methods; 1999. Alexandria, VA.